Update on treatment of B-cell lymphoma from Dr Breen.
Grant 02309-T Update End Year 3: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Update on targeting epigenome for treatment of B-cell lymphoma from Dr McCleary-Wheeler.
Research Update Mid-Year-2 CHF-02502: Precision Medicine for Canine Lymphoma
Research update from Dr. Nicola Mason to profile lymphoma and enable targeted therapy.
Continue reading “Research Update Mid-Year-2 CHF-02502: Precision Medicine for Canine Lymphoma”
Research Final Update CHF-02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs
Final Research Update from Dr. Trepanier on genetic and environmental risks of lymphoma in Boxer dogs.
Research Update Mid-Year 3 CHF-02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma
Research Update from Dr. Breen regarding aiding prognosis of Canine Diffuse Large B-Cell Lymphoma.
Research Update Mid-year 3 CHF 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Research Update from Dr. McCleary-Wheeler targeting epigenetics in Lymphoma.
Research Update End-Year-2 CHF 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Research Update from Dr. McCleary-Wheeler targeting epigenetics in Lymphoma.
Research Update End-Year 2 CHF-02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma
Research Update from Dr. Breen regarding aiding prognosis of Canine Diffuse Large B-Cell Lymphoma.
Research Update End-Year 2 CHF-02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs
Research Update from Dr. Trepanier on genetic and environmental risks of lymphoma in Boxer dogs.
Research Update End-Year-1 CHF-02502: Precision Medicine for Canine Lymphoma
Research update from Dr. Nicola Mason to profile lymphoma and enable targeted therapy.
Continue reading “Research Update End-Year-1 CHF-02502: Precision Medicine for Canine Lymphoma”
